Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Optimal management of cancer treatment-induced bone loss: considerations for elderly patients.

Tipples K, Robinson A.

Drugs Aging. 2011 Nov 1;28(11):867-83. doi: 10.2165/11595820-000000000-00000. Review.

PMID:
22054228
[PubMed - indexed for MEDLINE]
2.

Managing cancer treatment-induced bone loss and osteoporosis in patients with breast or prostate cancer.

Michaud LB.

Am J Health Syst Pharm. 2010 Apr;67(7 Suppl 3):S20-30; quiz S31-3. doi: 10.2146/ajhp100078.

PMID:
20332495
[PubMed - indexed for MEDLINE]
3.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
[PubMed - indexed for MEDLINE]
4.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
5.

Background to and management of treatment-related bone loss in prostate cancer.

Berruti A, Tucci M, Terrone C, Gorzegno G, Scarpa RM, Angeli A, Dogliotti L.

Drugs Aging. 2002;19(12):899-910. Review.

PMID:
12495366
[PubMed - indexed for MEDLINE]
6.

The role of bisphosphonates in breast and prostate cancers.

Brown JE, Neville-Webbe H, Coleman RE.

Endocr Relat Cancer. 2004 Jun;11(2):207-24. Review.

PMID:
15163299
[PubMed - indexed for MEDLINE]
Free Article
7.

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.

Hillner BE, Ingle JN, Berenson JR, Janjan NA, Albain KS, Lipton A, Yee G, Biermann JS, Chlebowski RT, Pfister DG.

J Clin Oncol. 2000 Mar;18(6):1378-91.

PMID:
10715310
[PubMed - indexed for MEDLINE]
8.

Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.

Reid DM, Doughty J, Eastell R, Heys SD, Howell A, McCloskey EV, Powles T, Selby P, Coleman RE.

Cancer Treat Rev. 2008;34 Suppl 1:S3-18. doi: 10.1016/j.ctrv.2008.03.007. Epub 2008 Jun 2.

PMID:
18515009
[PubMed - indexed for MEDLINE]
9.

Bone health in men receiving androgen deprivation therapy for prostate cancer.

Eastham JA.

J Urol. 2007 Jan;177(1):17-24. Review.

PMID:
17161994
[PubMed - indexed for MEDLINE]
10.

Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.

Higano CS.

Urol Clin North Am. 2004 May;31(2):331-52. Review.

PMID:
15123412
[PubMed - indexed for MEDLINE]
11.

Bone density measurement--a systematic review. A report from SBU, the Swedish Council on Technology Assessment in Health Care.

[No authors listed]

J Intern Med Suppl. 1997;739:1-60. Review.

PMID:
9104441
[PubMed - indexed for MEDLINE]
12.

Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors.

Brown-Glaberman U, Stopeck AT.

Biologics. 2012;6:89-99. doi: 10.2147/BTT.S20677. Epub 2012 Apr 12.

PMID:
22532777
[PubMed]
Free PMC Article
13.

Practical guidance for the management of aromatase inhibitor-associated bone loss.

Hadji P, Body JJ, Aapro MS, Brufsky A, Coleman RE, Guise T, Lipton A, Tubiana-Hulin M.

Ann Oncol. 2008 Aug;19(8):1407-16. doi: 10.1093/annonc/mdn164. Epub 2008 Apr 29.

PMID:
18448451
[PubMed - indexed for MEDLINE]
Free Article
14.

Calcium and vitamin D nutrition and bone disease of the elderly.

Gennari C.

Public Health Nutr. 2001 Apr;4(2B):547-59. Review.

PMID:
11683549
[PubMed - indexed for MEDLINE]
15.

Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.

Reginster JY.

Drugs. 2011 Jan 1;71(1):65-78. doi: 10.2165/11587570-000000000-00000. Review.

PMID:
21175240
[PubMed - indexed for MEDLINE]
16.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

PMID:
18088161
[PubMed - indexed for MEDLINE]
Free Article
17.

Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly.

Reimer T, Gerber B.

Drugs Aging. 2010 Oct 1;27(10):791-800. doi: 10.2165/11584700-000000000-00000. Review.

PMID:
20883059
[PubMed - indexed for MEDLINE]
18.

Emerging bone health issues in women with breast cancer in Hawai'i.

Carney JF, Davis J.

Hawaii Med J. 2007 Jun;66(6):164-6.

PMID:
17621865
[PubMed - indexed for MEDLINE]
19.

Early breast cancer in the elderly: assessment and management considerations.

Albrand G, Terret C.

Drugs Aging. 2008;25(1):35-45. Review.

PMID:
18184027
[PubMed - indexed for MEDLINE]
20.

Bone loss and fracture risk associated with cancer therapy.

Guise TA.

Oncologist. 2006 Nov-Dec;11(10):1121-31. Review.

PMID:
17110632
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk